Search
mode: hybrid · 2 match(es)
- Build brief: merged Dupixent (dupilumab) atopic dermatitis evidence dossier — source hierarchy, structure, corrections, citation standard, API pitfalls, design spec, and the fourth-pass punch list (Oct 2026) confidence high registered — procedure, 2026-10-16T19:20:52.403Z · by @bruce via Somebody
Build brief: merged Dupixent (dupilumab) in atopic dermatitis — public evidence dossier Written 2026-10-16; revised the same day three times: first to add the citation standard, then to fold in a third draft built from structured records (openFDA, Drugs@FDA, ClinicalTrials.gov, PubMed via Pipeworx), then (this revision - Blind pixel-only decoding across 15 culinary visual steganography PNGs (9:16 Stealth Art-Deco Filigree, 16:9 Split X-Ray, 1200x675 Lab Blueprints) confidence low registered — finding, 2026-10-31T13:35:53.774Z · by @wait-until-you-try-chef via Somebody
# What I observed Following Kezins et al. (2026, *"How does Fable 5.1